openPR Logo
Press release

Shrimp Disease Diagnostics Market Worth USD 271.53 Million by the end 2025

04-18-2020 12:25 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Shrimp Disease Diagnostics Market Worth USD 271.53 Million

The Global Shrimp Disease Diagnostics Market Size is expected to grow from USD 141.18 Million in 2019 to USD 271.53 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.51%.

Inquire for Free Sample Report: https://reports.valuates.com/request/sample/360I-Auto-8U20/shrimp_disease_diagnostics_market

Market Segmentation & Coverage:

This research report categorizes the Shrimp Disease Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:


"The Yellow Head or Gill Associated Virus is projected to witness the highest growth during the forecast period"

On the basis of Disease, the Shrimp Disease Diagnostics Market is studied across Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus, and Yellow Head or Gill Associated Virus. The Early Mortality Syndrome commanded the largest size in the Shrimp Disease Diagnostics Market in 2019. On the other hand, the Yellow Head or Gill Associated Virus is expected to grow at the fastest CAGR during the forecast period.

View Full Report:https://reports.valuates.com/market-reports/360I-Auto-8U20/shrimp-disease-diagnostics-market

"The Assay Based Kit is projected to witness the highest growth during the forecast period"

On the basis of Kit, the Shrimp Disease Diagnostics Market is studied across Assay Based Kit and Rapid Testing Kit. The Assay Based Kit commanded the largest size in the Shrimp Disease Diagnostics Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.


"The Fisheries is projected to witness the highest growth during the forecast period"

On the basis of End User, the Shrimp Disease Diagnostics Market is studied across Aquaculture & Marine Laboratories, Education & Research Institutes, and Fisheries. The Aquaculture & Marine Laboratories commanded the largest size in the Shrimp Disease Diagnostics Market in 2019. On the other hand, the Fisheries is expected to grow at the fastest CAGR during the forecast period.


"The Asia-Pacific is projected to witness the highest growth during the forecast period"

On the basis of Geography, the Shrimp Disease Diagnostics Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded the largest size in the Shrimp Disease Diagnostics Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

Get Free Sample Report: https://reports.valuates.com/request/sample/360I-Auto-8U20/shrimp_disease_diagnostics_market

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Shrimp Disease Diagnostics Market including AquaBounty Technologies, Inc., Auro Biotechnologies, FUJIKURA KASEI CO., LTD, GeneReach Biotechnology Corp, HiMedia Laboratorie, Lab - Ind Resource Sdn Bhd., REAGEN LLC, Speedy Assay Sdn Bhd, SUREBIO, and Thermo Fisher Scientific Inc..

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp : +91-9945648335

Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports/

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of Silicon Valley of India (Bengaluru) and provide 24/6 online and offline support to all our customers and just a phone call away.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Shrimp Disease Diagnostics Market Worth USD 271.53 Million by the end 2025 here

News-ID: 2015758 • Views:

More Releases from Valuates Reports

Data Center Substation Market Set to Surge - Key Insights You Must Know
Data Center Substation Market The global market for Data Center Substation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15H10205/Global_Data_Center_Substation_Market_Research_Report_2022 North American market for Data Center Substation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of %
Antistatic HPL Raised Floor Market Set to Surge - Key Insights You Must Know
Antistatic HPL Raised Floor Market Size The global market for Antistatic HPL Raised Floor was valued at US$ 794 million in the year 2024 and is projected to reach a revised size of US$ 1125 million by 2031, growing at a CAGR of 5.1% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3F17863/Global_Antistatic_HPL_Raised_Floor_Market_Research_Report_2024 The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent
State-of-the-Art Data Centers Market Set to Surge - Key Insights You Must Know
State-of-the-Art Data Centers Market Size The global market for State-of-the-Art Data Centers was valued at US$ 15430 million in the year 2024 and is projected to reach a revised size of US$ 30760 million by 2031, growing at a CAGR of 9.7% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-20U19339/Global_State_of_the_Art_Data_Centers_Market_Research_Report_2025 These data centers incorporate the latest technologies in hardware, software, and networking, including high-performance servers, advanced cooling systems, energy-efficient designs, and robust cybersecurity
AI Server GPU Market Set to Surge - Key Insights You Must Know
AI Server GPU Market Size The global market for AI Server GPU was valued at US$ 1430 million in the year 2024 and is projected to reach a revised size of US$ 4154 million by 2031, growing at a CAGR of 16.7% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-34U16081/Global_AI_Server_GPU_Market_Research_Report_2024 This report aims to provide a comprehensive presentation of the global market for AI Server GPU, with both quantitative and qualitative analysis, to

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and